Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
tariffs
Pharma
Kedrion wins FDA nod for immunodeficiency disorder treatment
Italian plasma specialist Kedrion has scored an FDA approval for Qivigy, a treatment for a adults with primary humoral immunodeficiency.
Kevin Dunleavy
Sep 29, 2025 11:39am
Trump's pharma tariffs offer some relief, many unknowns
Sep 26, 2025 11:16am
Amgen lays out $650M to grow Puerto Rico site
Sep 26, 2025 10:40am
Korea's Celltrion throws down $330M for Lilly plant in N.J.
Sep 23, 2025 9:24am
Fujifilm, argenx move to bring Vyvgart production to the US
Sep 18, 2025 3:24pm
Samsung Bio inks US contract manufacturing deal worth $1.3B
Sep 9, 2025 8:52am
